
Once-monthly oral PrEP moves into late-stage trials
An investigational once-monthly pill holds promise for HIV pre-exposure prophylaxis (PrEP), according to mid-stage study results presented yesterday at the 13th International AIDS Society Conference on HIV Science (IAS 2025). With favourable …